MedPath

SQUAREX, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)

Phase 1
Completed
Conditions
HSV
Herpes Labialis
Interventions
First Posted Date
2018-09-07
Last Posted Date
2021-11-03
Lead Sponsor
Squarex, LLC
Target Recruit Count
36
Registration Number
NCT03661541
Locations
🇺🇸

Prism Clinical Research, LLC, Saint Paul, Minnesota, United States

A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis

Phase 2
Terminated
Conditions
HSV
Herpes Labialis
Interventions
First Posted Date
2018-05-11
Last Posted Date
2021-08-06
Lead Sponsor
Squarex, LLC
Target Recruit Count
40
Registration Number
NCT03521479
Locations
🇺🇸

International Research Partners, LLC, Doral, Florida, United States

🇺🇸

Prism Clinical Research, LLC, Saint Paul, Minnesota, United States

Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis

Phase 1
Completed
Conditions
Herpes Labialis
Cold Sore
Interventions
Other: Placebo
First Posted Date
2016-11-17
Last Posted Date
2021-11-02
Lead Sponsor
Squarex, LLC
Target Recruit Count
139
Registration Number
NCT02965781
Locations
🇺🇸

Stanford Medicine Outpatient Center, Redwood City, California, United States

🇺🇸

International Research Partners, LLC, Doral, Florida, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.